Collection Medium Shapes MSC Exosome Potency More Than Previously Recognized
New research reveals the culture medium used to collect stem cell-derived vesicles dramatically alters their anti-inflammatory and tissue-repair activity.
Summary
Researchers at Evercyte GmbH and BOKU University tested extracellular vesicles (EVs) harvested from hTERT-immortalised bone marrow mesenchymal stromal cells using four different xeno-free collection media. EVs were concentrated via tangential flow filtration (TFF) and evaluated in standardised assays for anti-inflammatory, anti-fibrotic, wound-closure, and proliferative activity. Critically, unconditioned versions of each medium were processed identically as controls, allowing the team to separate EV-specific effects from soluble media components. Results showed that collection medium composition significantly altered EV biological activity across all assays, sometimes independent of particle yield or size. The findings underscore that medium selection is a major, underappreciated variable in EV manufacturing and must be standardised for reproducible, clinically translatable MSC-EV therapeutics.
Detailed Summary
Extracellular vesicles (EVs) secreted by mesenchymal stromal cells (MSCs) are widely studied as cell-free regenerative medicines, capable of immunomodulation, tissue repair, and anti-inflammatory signalling. However, translating MSC-EVs into consistent therapeutic products is hampered by biological and technical variability at nearly every production step. This study directly addresses one underexplored variable: the composition of the medium in which EVs are collected.
To minimise donor and passage-related cellular variability, the authors used hTERT-immortalised bone marrow MSCs (BM-MSC/TERT292), a stable, scalable cell line that preserves the therapeutic properties of primary MSCs. Cells were expanded in two commercially available xeno-free media—Mesencult ACF Plus and RoosterNourish-MSC-XF—and then switched for 48 hours to paired collection media (OptiMEM or RoosterCollect-EV, respectively), generating four distinct EV-conditioned medium preparations. All samples were enriched using tangential flow filtration (TFF) with 300 kDa hollow fibre columns. Importantly, unconditioned versions of each medium were processed through the identical TFF workflow to serve as matched controls—a methodological safeguard rarely implemented in prior EV studies.
EV preparations were characterised by nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), and protein quantification to confirm vesicle morphology, size distribution, and purity. Functional bioactivity was then assessed across four standardised assays: LPS-stimulated BV-2 microglial cell inflammation (anti-inflammatory), TGF-β-induced fibroblast fibrosis (anti-fibrotic), scratch wound closure, and proliferation assays using relevant reporter cell lines.
The central finding was that collection medium composition significantly modulated EV biological activity in all four functional assays—sometimes in opposing directions depending on which medium was used. Notably, some differences in bioactivity mirrored effects seen in unconditioned medium controls, confirming that soluble components co-concentrated during TFF can contribute meaningfully to measured outcomes. This highlights a critical confound in EV bioassay interpretation: without process-matched unconditioned medium controls, it is impossible to attribute functional effects solely to EVs. When EV-specific effects were isolated by comparing conditioned versus unconditioned matched controls, medium-dependent differences in true EV bioactivity remained apparent, confirming that collection medium influences not just co-isolated contaminants but the intrinsic biological cargo of the vesicles themselves.
These findings have direct implications for EV manufacturing standardisation. The choice of collection medium affects both the molecular composition of secreted EVs (potentially through altered cellular signalling during the collection window) and the background bioactivity introduced by co-concentrated media components. The study provides a practical framework—using immortalised cells, TFF enrichment, and matched UCM controls—that can serve as a methodological standard for more rigorous, reproducible EV research and product development.
Key Findings
- Collection medium composition significantly altered anti-inflammatory, anti-fibrotic, wound-closure, and proliferative activity of MSC-derived EVs.
- Unconditioned media processed identically via TFF contributed measurable bioactivity, confounding EV-specific effect attribution in standard assays.
- hTERT-immortalised MSCs provided a stable, reproducible EV source, reducing donor and passage variability.
- Process-matched unconditioned medium controls are essential to accurately isolate true EV-specific biological effects.
- Medium selection must be considered a critical quality attribute in standardised MSC-EV therapeutic manufacturing.
Methodology
hTERT-immortalised bone marrow MSCs were cultured in four xeno-free media combinations and EVs were enriched via 300 kDa TFF. Functional bioactivity was assessed in anti-inflammatory (BV-2), anti-fibrotic (fibroblast), wound-closure, and proliferation assays, with process-matched unconditioned media as controls across three independent batches per condition.
Study Limitations
The study used a single immortalised MSC line, so findings may not fully generalise to primary MSC populations or other tissue sources. Only four medium combinations were tested, and in vitro functional assays may not predict in vivo therapeutic outcomes with certainty.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
